| 51479-4 |
Spermatozoa |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Spermatozoa [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51479-4 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Sperm # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Sperm; UA; UR; URINALYSIS; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 5148-2 |
Echovirus Ab.Neut |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Echovirus neutralizing antibody [Titer] in Serum by Neutralization test |
|
NAM |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5148-2 |
|
Neut |
|
|
Both |
|
|
|
0 |
ECV NAb Titr Ser Nt |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; ECV; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT |
2.78 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.78: COMPONENT: Maintenance ; Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; |
0 |
| 51480-2 |
Bacteria |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Bacteria [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51480-2 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Bacteria # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Bact; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; ID; Infectious Disease; InfectiousDisease; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51481-0 |
Yeast |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Yeast [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51481-0 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Yeast # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; ID; Infectious Disease; InfectiousDisease; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51482-8 |
Crystals |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Crystals [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51482-8 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Crystals # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; Crys; Cryst; Crystal; CT; Elec; Elect; Electr; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn |
2.42 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51483-6 |
Casts |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Casts [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51483-6 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Casts # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cast; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn |
2.42 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51484-4 |
Hyaline casts |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Hyaline casts [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51484-4 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Hyaline Casts # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cast; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Kidney; Nephrology; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51485-1 |
Epithelial cells.non-squamous |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Epithelial cells.non-squamous [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51485-1 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Non-sq Epi Cells # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Epi; Epi Cells; Epith; Epithelia; Non-sq Epi Cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Round epithelial cells; Small epithelial cells; Sq; UA; UR; URINALYSIS; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51486-9 |
Epithelial cells.squamous |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Epithelial cells.squamous [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51486-9 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Squamous # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Epi; Epi Cells; Epith; Epithelia; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells; UA; UR; URINALYSIS; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51487-7 |
Leukocytes |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Leukocytes [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51487-7 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
WBC # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 51488-5 |
Cortisol^6th specimen post XXX challenge |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --6th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51488-5 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis sp6 p chal Sal-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp6; sp6 p chal; Spec |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 51489-3 |
Cortisol^7th specimen post XXX challenge |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --7th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51489-3 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis sp7 p chal Sal-mCnc |
|
|
|
N |
|
^7th spec pst XXX chal; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp7; sp7 p chal; Spec |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 5149-0 |
Echovirus Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Echovirus Ab [Titer] in Serum by Complement fixation |
|
NAM |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5149-0 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
ECV Ab Titr Ser CF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; ECV; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.79 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: Removing NOS from component; |
0 |
| 51490-1 |
Cortisol^5th specimen post XXX challenge |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --5th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51490-1 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis sp5 p chal Sal-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp5; sp5 p chal; Spec |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 51491-9 |
Cortisol^4th specimen post XXX challenge |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --4th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51491-9 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis sp4 p chal Sal-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp4; sp4 p chal; Spec |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 51492-7 |
Cortisol^3rd specimen post XXX challenge |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --3rd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51492-7 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis sp3 p chal Sal-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp3; sp3 p chal; Spec |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 51493-5 |
Cortisol^2nd specimen post XXX challenge |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --2nd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51493-5 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis sp2 p chal Sal-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Convalescent; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Sal; Second; sp2; sp2 p chal; Spec |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 51494-3 |
Cortisol^1st specimen post XXX challenge |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --1st specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51494-3 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis sp1 p chal Sal-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; First; hydrocortisone; Level; Mass concentration; Oral fluid; p chal; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; Sal; sp1; sp1 p chal; Spec |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 51495-0 |
Cortisol^baseline |
MCnc |
Saliva |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Mass/volume] in Saliva (oral fluid) --baseline |
|
MIN |
DefinitionDescription |
|
|
pg/mL;ug/dL |
|
|
|
|
|
|
CHAL |
|
51495-0 |
|
|
|
|
Observation |
|
|
|
0 |
Cortis BS Sal-mCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; BS; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal |
2.73 |
2.24 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 51496-8 |
Estradiol^4th specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
51496-8 |
|
|
|
|
Observation |
|
|
|
0 |
Estradiol sp4 p chal SerPl-mCnc |
|
|
|
N |
|
17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR |
2.73 |
2.24 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 51497-6 |
Estradiol^5th specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
51497-6 |
|
|
|
|
Observation |
|
|
|
0 |
Estradiol sp5 p chal SerPl-mCnc |
|
|
|
N |
|
17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR |
2.7 |
2.24 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 51498-4 |
Estradiol^3rd specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
51498-4 |
|
|
|
|
Observation |
|
|
|
0 |
Estradiol sp3 p chal SerPl-mCnc |
|
|
|
N |
|
17-beta estradiol; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR |
2.73 |
2.24 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 51499-2 |
Estradiol^1st specimen post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
51499-2 |
|
|
|
|
Observation |
|
|
|
0 |
Estradiol sp1 p chal SerPl-mCnc |
|
|
|
N |
|
17-beta estradiol; Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; E2; First; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR |
2.73 |
2.24 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
| 515-7 |
Trimethoprim+Sulfamethoxazole |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
515-7 |
|
MLC |
|
|
Observation |
|
|
|
0 |
TMP SMX Islt MLC |
|
|
|
Y |
|
Acetylsulfamethoxazole; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bactrim; c202; c203; c223; c242; C61; C62; Cotrim; Cotrimoxazole; Co-trimoxazole; Gantanol; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; Polytrim; Primsol; Proloprim; QNT; Quan; Quant; Quantitative; Random; Septra; SMX; SMX-TMP; Sulfa; Sulfamethox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; SXT; TMP; TMP SMX; TMP-SMX; Trimeth; Trimpex |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 5150-8 |
Entamoeba histolytica Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Entamoeba histolytica Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5150-8 |
|
IA |
|
|
Both |
|
|
|
0 |
E histolyt Ab Ser IA-aCnc |
|
|
|
Y |
|
ABS; Aby; Ameba; Amebiasis; Amebic; Amoeba; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; E histolyt; E histolytica; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
